Impact of switching to second-generation antipsychotics on the treatment of long-term inpatients with schizophrenia

被引：0
|
作者：
Yamawaki, Y. [1 ]
Yoshino, A. [2 ]
Sawa, M. [2 ]
Jin-nin, R. [3 ]
Tamai, K. [2 ]
Adachi, T. [2 ]
Yukutake, E. [2 ]
Toki, S. [3 ]
Oyamada, T. [2 ]
Takahashi, T. [2 ]
Akagi, H. [4 ]
机构：
[1] Hiroshima Int Univ, Hiroshima, Japan
[2] Mihara Hosp, Kyoto, Japan
[3] Hiroshima Univ, Dept Psychiat, Hiroshima 730, Japan
[4] Hiroshima Int Univ, Dept Pharm, Kure, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-01-068
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [1] Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia
    Buoli, Massimiliano
    Kahn, Rene S.
    Serati, Marta
    Altamura, A. Carlo
    Cahn, Wiepke
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (04) : 325 - 331
  • [2] Long-term second-generation antipsychotics decreases bone formation and resorption in male patients with schizophrenia
    Wang, Fan
    Li, Hui
    Yi, Kaijun
    Wu, Yan
    Bian, Qingtao
    Guo, Baoyan
    Luo, Xingguang
    Kang, Yimin
    Wu, Qi
    Ma, Qinghe
    PSYCHOPHARMACOLOGY, 2024, 241 (09) : 1771 - 1780
  • [3] Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
    Jeong, Seong Hoon
    Lee, Nam Young
    Kim, Se Hyun
    Chung, In Won
    Youn, Tak
    Kang, Ung Gu
    Ahn, Yong Min
    You, Han Young
    Kim, Yong Sik
    PSYCHIATRY INVESTIGATION, 2018, 15 (06) : 628 - 637
  • [4] New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia
    Citrome, Leslie
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (07) : 767 - 783
  • [5] Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia
    Mallinger, JB
    Fisher, SG
    Brown, T
    Lamberti, JS
    PSYCHIATRIC SERVICES, 2006, 57 (01) : 133 - 136
  • [6] Cost-Effectiveness of Second-Generation Antipsychotics for the Treatment of Schizophrenia
    Park, Taehwan
    Kuntz, Karen M.
    VALUE IN HEALTH, 2014, 17 (04) : 310 - 319
  • [7] Systemwide costs associated with second-generation antipsychotics in the treatment of schizophrenia
    Sernyak, MJ
    Rosenheck, R
    PSYCHIATRIC SERVICES, 2004, 55 (12) : 1361 - 1362
  • [8] Long-term metabolic effect of second-generation antipsychotics in first episode of psychosis
    Vazquez Bourgon, J.
    Perez-Iglesias, R.
    Ortiz-Garcia de la Foz, V.
    Crespo-Facorro, B.
    EUROPEAN PSYCHIATRY, 2017, 41 : S388 - S388
  • [9] Haloperidol Versus Second-Generation Antipsychotics in the Long-Term Treatment of Schizophrenia A 4-Year Follow-Up Naturalistic Study
    Altamura, Alfredo Carlo
    Buoli, Massimiliano
    Mauri, Massimo Carlo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (05) : 661 - 663
  • [10] Second-generation antipsychotics and bone turnover in schizophrenia
    Okita, Kyoji
    Kanahara, Nobuhisa
    Nishimura, Motoi
    Yoshida, Toshihiko
    Yasui-Furukori, Norio
    Niitsu, Tomihisa
    Yoshida, Taisuke
    Ishikawa, Masatomo
    Kimura, Hiroshi
    Nomura, Fumio
    Iyo, Masaomi
    SCHIZOPHRENIA RESEARCH, 2014, 157 (1-3) : 137 - 141
12345